1. Home
  2. QSG vs CABA Comparison

QSG vs CABA Comparison

Compare QSG & CABA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QSG
  • CABA
  • Stock Information
  • Founded
  • QSG 2019
  • CABA 2017
  • Country
  • QSG China
  • CABA United States
  • Employees
  • QSG N/A
  • CABA N/A
  • Industry
  • QSG Other Consumer Services
  • CABA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • QSG Real Estate
  • CABA Health Care
  • Exchange
  • QSG Nasdaq
  • CABA Nasdaq
  • Market Cap
  • QSG 140.0M
  • CABA 118.8M
  • IPO Year
  • QSG 2023
  • CABA 2019
  • Fundamental
  • Price
  • QSG $4.28
  • CABA $1.10
  • Analyst Decision
  • QSG
  • CABA Strong Buy
  • Analyst Count
  • QSG 0
  • CABA 8
  • Target Price
  • QSG N/A
  • CABA $21.00
  • AVG Volume (30 Days)
  • QSG 2.3M
  • CABA 1.0M
  • Earning Date
  • QSG 06-05-2025
  • CABA 05-14-2025
  • Dividend Yield
  • QSG 4.71%
  • CABA N/A
  • EPS Growth
  • QSG 101.59
  • CABA N/A
  • EPS
  • QSG 1.04
  • CABA N/A
  • Revenue
  • QSG $477,141,565.00
  • CABA N/A
  • Revenue This Year
  • QSG N/A
  • CABA N/A
  • Revenue Next Year
  • QSG $6.09
  • CABA N/A
  • P/E Ratio
  • QSG $4.13
  • CABA N/A
  • Revenue Growth
  • QSG N/A
  • CABA N/A
  • 52 Week Low
  • QSG $1.47
  • CABA $0.99
  • 52 Week High
  • QSG $7.96
  • CABA $16.36
  • Technical
  • Relative Strength Index (RSI)
  • QSG 55.22
  • CABA 34.66
  • Support Level
  • QSG $3.88
  • CABA $1.01
  • Resistance Level
  • QSG $4.74
  • CABA $1.29
  • Average True Range (ATR)
  • QSG 0.99
  • CABA 0.14
  • MACD
  • QSG -0.09
  • CABA 0.01
  • Stochastic Oscillator
  • QSG 18.40
  • CABA 21.76

About QSG QuantaSing Group Limited

QuantaSing Group Ltd is a learning service provider in China's adult learning market for personal interest courses. It offers easy-to-understand, affordable, and accessible online courses to adult learners under various brands, including QiNiu, Kelly, and QianChi among others empowering them to pursue personal development. The company offers courses for various domains such as financial literacy, skill upgrading, recreation, and leisure which are offered in live large-class dual-instructor mode, online community-based training camp mode, and in live lecture, one-on-one tutoring mode. Its segments are; Learning service and others which derives key revenue, and Consumer business. Geographically, the company generates all of its revenue from the People's Republic of China.

About CABA Cabaletta Bio Inc.

Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies, and exploring their potential to provide a deep and durable, perhaps curative, treatment, for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) has the potential to be applied across a broad range of autoimmune diseases.

Share on Social Networks: